Polypoidal Choroidal Vasculopathy: Clinical Trials

1 trial for Polypoidal Choroidal Vasculopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Zimura, Eylea - Idiopathic Polypoidal Choroidal Vasculopathy
Phase 2WithdrawnOphthotech Corporation2018-11-012024-02-21

Broader conditions

Choroid Diseases (1)  ·  Choroidal Neovascularization (1)  ·  Eye Diseases (1)  ·  Metaplasia (1)  ·  Neovascularization, Pathologic (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Uveal Diseases (1)

Interventions

aflibercept (1)

Sponsors

Ophthotech Corporation (1)

Countries

United States (1)